United States HR 5133: Affordable Prescriptions for Patients Through Promoting Competition Act of 2019

Status: Reported by the Committee on Judiciary. H. Rept. 116-695. (as of 2020-12-24)

State: United States · Session: 116 · Bill: HR 5133

Subjects: Administrative remedies, Civil actions and liability, Competition and antitrust, Consumer affairs, Drug safety, medical device, and laboratory regulation, Federal Trade Commission (FTC), Health care costs and insurance, Inflation and prices, Intellectual property, Judicial review and appeals, Manufacturing, Prescription drugs

Sponsors: David N. Cicilline, Ben Cline, Doug Collins, F. JAMES SENSENBRENNER, JERROLD NADLER, Lucy McBath

View United States HR 5133 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.